An audit to summarise is an independent evaluations of activities, processes and product quality which have become a routine element of quality management and in most sectors the process of carrying out audits is mandatory. This too is the case for the pharmaceutical industry and drug development industry, where audits of clinical trial activities have become a key part of the development process since the implementation of ICH E6 in 1997. Audits of clinical trials are usually undertaken by an independent team of specialist auditors within the company or they are generally outsourced to a third party service provider.
He has over 25 years’ experience working within the clinical audit side of pharmaceuticals and holds 2 nationally recognised teaching qualifications in Europe.
18th -19th November 2015, London, UK
For more details on the above, please fill in the registration form. You will also receive a link to download the full agenda.